Krónikus obstruktív tüdőbetegség (COPD): vizsgálatok itt: Mexikó
8 trials · From ClinicalTrials.gov, checked 2026. november 11.. Ask the study team whether a trial fits you.
- No phaseTaking peopleStudy of Clinical and Patient-reported Outcomes in Adults With Moderate to Severe COPD Treated With Breztri/Trixeo
- Where
- Guadalajara, Mexico City, Monterrey
- Életkor
- 30 év to 80 év
- People
- 1400 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT07069829 - 2. fázisTaking peopleA Study of Brenipatide (LY3537031) in Adult Participants With Moderate-to-Severe Chronic Obstructive Pulmonary Disease (COPD)
- Where
- Chihuahua City, Mérida, San Nicolás de los Garza, Tlalpan
- Életkor
- 40 év to 75 év
- People
- 606 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT07759245 · EU 2026-525480-41-00 - 2. fázisTaking peopleA Study to Investigate the Effect of AZD6793 in Participants With Moderate to Very Severe Chronic Obstructive Pulmonary Disease
- Where
- Chihuahua City, Durango, Guadalajara, Mexico City, Monterrey
- Életkor
- 40 év and over
- People
- 987 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT07082738 - 3. fázisTaking peopleEfficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD), Characterized by an Eosinophilic Phenotype
- Where
- Chihuahua City, Durango, Guadalajara, León, Mexico City
- Életkor
- 40 év to 80 év
- People
- 942 worldwide
- Run by
- Sanofi
See details and how to joinNCT07190222 · EU 2024-518213-25-00 - 3. fázisTaking peopleEfficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD) Characterized by an Eosinophilic Phenotype
- Where
- Durango, Mexico City, Monterrey, San Juan del Río, Veracruz
- Életkor
- 40 év to 80 év
- People
- 942 worldwide
- Run by
- Sanofi
See details and how to joinNCT07190209 · EU 2024-518016-39-00 - No phaseTaking peopleAssess Accuracy of Primary Care Asthma and COPD Diagnosis Using Oscillometry and FeNO vs Specialist Diagnosis
- Where
- Monterrey, Santiago de Quer Taro
- Életkor
- 18 év and over
- People
- 600 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT07245576 - 3. fázisTaking peopleA Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease
- Where
- Benito Juárez, Chihuahua City, Cuernavaca, Culiacán, Guadalajara, Juriquilla, Mérida, Metepec, Mexico City, Monterrey, Oaxaca City, Tijuana, Veracruz, Xalapa, Zapopan
- Életkor
- 40 év to 80 év
- People
- 5250 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT06283966 · EU 2023-507407-59-00 - 3. fázisTaking peopleA Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00006)
- Where
- Benito Juárez, Chihuahua City, Cuauhtémoc, Cuernavaca, Guadalajara, Mérida, Monterrey, Morelia, Oaxaca City, San Juan del Río, Tijuna, Veracruz, Zapopan
- Életkor
- 40 év to 80 év
- People
- 990 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT06883305 · EU 2024-517458-90-00